BRCA2 and central nervous system neoplasm: Patients with CNS tumors harbored germline pathogenic or likely pathogenic variants in 8 of 149 cases (5%): five in NF1, two in BRCA2 and one in PMS2; all genes previously reported in patients with CNS tumors5,18–20.